Andrew W. Schally (USA) - GYTK

Professor Andrew V. Schally received his training in England and Canada. He started his research work at the National Institute for Medical Research in London, England in 1950 and received his Ph.D. degree in Endocrinology/Biochemistry from McGill University, Montreal, Canada, in 1957. The same year he joined the Department of Physiology at Baylor University, School of Medicine in Houston, Texas, where he continued his work on the hypothalamus. He became a naturalized citizen of the United States in 1962 and joined the staff of the Veterans Administration Hospital in New Orleans. He also became Associate Professor and then Professor in the Department of Medicine at Tulane University School of Medicine, New Orleans, Louisiana. After hurricane Katrina in August 2005, Dr. Schally joined the faculty of the University of Miami Miller School of Medicine, Miami, Florida and the VA Medical Center at Miami. At present he is Chief of the new Endocrine, Polypeptide and Cancer Institute at the VA Medical Center in Miami and Distinguished Medical Research Scientist of the Veterans Affairs Department, U.S.A. Dr. Schally is currently Distinguished Leonard M. Miller Professor of Pathology and also Professor of Medicine in the Division of Hematology/Oncology at the University of Miami, Miller School of Medicine.
For his research in the hypothalamic hormones he received many honors and awards including the Charles Mickle Award, Gairdner Award from Canada, Albert Lasker Award and most importantly for his work in Neuroendocrinology he was awarded the Nobel Prize in Physiology and Medicine in 1977. Fluent in several languages, Dr. Schally has 33 awards and more than 30 honorary degrees to his credit and belongs to more than 40 scientific organizations worldwide. In 2004 he also received the French Legion d’Honeur for saving thousands of lives by developing modern methods of cancer treatment. He has authored and co-authored more than 2300 scientific publications in the field of endocrinology and oncology.
Dr. Schally’s discoveries laid the foundation of modern endocrinology. Consequently he pioneered the application of analogs of hypothalamic hormones and targeted cytotoxic peptide analogs in the field of cancer treatment.
Dr. Andrew V. Schally has a very valuable and intensive scientific co-operation with the University of Debrecen especially with the Department of Biopharmacy, Faculty of Pharmacy. Our joint research has already resulted in numerous scientific papers, book chapters, other publications, PhD. Thesis and personal exchange visits are focusing on the expression and pathophysiological function of peptide hormone receptors and the development of peptide hormone analogs for targeted cancer therapy. This research should lead to the development of novel, innovative, cost-effective therapies for these malignancies and the experience from laboratory and animal research is rapidly translated to clinical research and patient care.
On these grounds, in the name of the Council of the Faculty of Pharmacy, I propose that the Senate of the University confer the title ’doctor honoris causa’ of our university on Dr. Andrew V. Schally.

Frissítés dátuma: 2017.08.14.

Tisztelt Felhasználó!


A Debreceni Egyetem kiemelt fontosságúnak tartja a rendelkezésére bocsátott, illetve birtokába jutott személyes adatok védelmét. Ezúton tájékoztatjuk Önt, hogy a Debreceni Egyetem a 2018. május 25. napjától kötelezően alkalmazandó Általános Adatvédelmi Rendelet alapján felülvizsgálta folyamatait és beépítette a GDPR előírásait az adatkezelési és adatvédelmi tevékenységébe. A felhasználók személyes adatait a Debreceni Egyetem korábban is teljes körültekintéssel kezelte, megfelelve az érvényben lévő adatkezelési szabályozásoknak. A GDPR előírásait követve frissítettük Adatvédelmi Tájékoztatónkat, amelyet az alábbi linkre kattintva olvashat el: Adatkezelési tájékoztató. DE Kancellária VIR Központ

A tájékoztatót megismertem.